NM_001042492.3:c.60+5C>G

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6_Very_StrongBS2_Supporting

The NM_001042492.3(NF1):​c.60+5C>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000065 in 1,539,318 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 29)
Exomes 𝑓: 0.0000058 ( 0 hom. )

Consequence

NF1
NM_001042492.3 splice_region, intron

Scores

2
Splicing: ADA: 0.002538
2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.945

Publications

0 publications found
Variant links:
Genes affected
NF1 (HGNC:7765): (neurofibromin 1) This gene product appears to function as a negative regulator of the ras signal transduction pathway. Mutations in this gene have been linked to neurofibromatosis type 1, juvenile myelomonocytic leukemia and Watson syndrome. The mRNA for this gene is subject to RNA editing (CGA>UGA->Arg1306Term) resulting in premature translation termination. Alternatively spliced transcript variants encoding different isoforms have also been described for this gene. [provided by RefSeq, Jul 2008]
MIR4733HG (HGNC:55332): (MIR4733 host gene)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant 17-31095374-C-G is Benign according to our data. Variant chr17-31095374-C-G is described in CliVar as Likely_benign. Clinvar id is 457777.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-31095374-C-G is described in CliVar as Likely_benign. Clinvar id is 457777.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-31095374-C-G is described in CliVar as Likely_benign. Clinvar id is 457777.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-31095374-C-G is described in CliVar as Likely_benign. Clinvar id is 457777.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-31095374-C-G is described in CliVar as Likely_benign. Clinvar id is 457777.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-31095374-C-G is described in CliVar as Likely_benign. Clinvar id is 457777.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-31095374-C-G is described in CliVar as Likely_benign. Clinvar id is 457777.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-31095374-C-G is described in CliVar as Likely_benign. Clinvar id is 457777.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-31095374-C-G is described in CliVar as Likely_benign. Clinvar id is 457777.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-31095374-C-G is described in CliVar as Likely_benign. Clinvar id is 457777.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAdExome4 at 8 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NF1NM_001042492.3 linkc.60+5C>G splice_region_variant, intron_variant Intron 1 of 57 ENST00000358273.9 NP_001035957.1 P21359-1
MIR4733HGNR_186435.1 linkn.117G>C non_coding_transcript_exon_variant Exon 1 of 4
NF1NM_000267.4 linkc.60+5C>G splice_region_variant, intron_variant Intron 1 of 56 NP_000258.1 P21359-2
NF1NM_001128147.3 linkc.60+5C>G splice_region_variant, intron_variant Intron 1 of 14 NP_001121619.1 P21359-5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NF1ENST00000358273.9 linkc.60+5C>G splice_region_variant, intron_variant Intron 1 of 57 1 NM_001042492.3 ENSP00000351015.4 P21359-1

Frequencies

GnomAD3 genomes
AF:
0.0000132
AC:
2
AN:
151968
Hom.:
0
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.0000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000577
AC:
8
AN:
1387350
Hom.:
0
Cov.:
32
AF XY:
0.00000584
AC XY:
4
AN XY:
684616
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31542
American (AMR)
AF:
0.00
AC:
0
AN:
35648
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25098
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35888
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79120
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
39688
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4208
European-Non Finnish (NFE)
AF:
0.00000742
AC:
8
AN:
1078412
Other (OTH)
AF:
0.00
AC:
0
AN:
57746
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000132
AC:
2
AN:
151968
Hom.:
0
Cov.:
29
AF XY:
0.0000135
AC XY:
1
AN XY:
74214
show subpopulations
African (AFR)
AF:
0.0000242
AC:
1
AN:
41382
American (AMR)
AF:
0.00
AC:
0
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5152
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
67950
Other (OTH)
AF:
0.00
AC:
0
AN:
2082
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.550
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.0000585
Hom.:
0
Bravo
AF:
0.0000113

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Neurofibromatosis, type 1 Benign:1
Dec 22, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary cancer-predisposing syndrome;CN230736:Cardiovascular phenotype Benign:1
Jan 29, 2020
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.47
CADD
Benign
19
DANN
Benign
0.89
PhyloP100
0.94
PromoterAI
0.054
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=78/22
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0025
dbscSNV1_RF
Benign
0.092
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs879413062; hg19: chr17-29422392; API